Takara Bio, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3460200003
JPY
768.00
-4 (-0.52%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
9,266.00
15,757.00
9,524.00
11,265.00
8,493.00
13,771.00
10,618.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
9,266.00
15,757.00
9,524.00
11,265.00
8,493.00
13,771.00
10,618.00
Raw Material Cost
4,262.00
6,060.00
5,599.00
3,174.00
4,139.00
4,905.00
5,920.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
117.00
5.00
5.00
3.00
7.00
5.00
6.00
Selling and Distribution Expenses
4,820.00
4,182.00
4,192.00
4,108.00
4,025.00
3,996.00
3,933.00
Other Expenses
167.00
177.40
163.20
177.20
169.90
220.00
187.20
Total Expenditure (Excl Depreciation)
10,869.00
12,021.00
11,428.00
9,057.00
9,870.00
11,106.00
11,731.00
Operating Profit (PBDIT) excl Other Income
-1603
3736
-1904
2208
-1377
2665
-1113
Other Income
102.00
1.00
83.00
-1.00
133.00
-175.00
67.00
Operating Profit (PBDIT)
-334.00
4,841.00
-700.00
3,182.00
-363.00
3,706.00
310.00
Interest
117.00
5.00
5.00
3.00
7.00
5.00
6.00
Exceptional Items
29.00
-349.00
0.00
-109.00
0.00
-132.00
-75.00
Gross Profit (PBDT)
5,004.00
9,697.00
3,925.00
8,091.00
4,354.00
8,866.00
4,698.00
Depreciation
1,360.00
1,104.00
1,107.00
1,132.00
1,138.00
1,216.00
1,316.00
Profit Before Tax
-1,782.00
3,381.00
-1,811.00
1,934.00
-1,507.00
2,353.00
-1,088.00
Tax
-289.00
947.00
67.00
371.00
-475.00
1,020.00
-166.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-1,510.00
2,420.00
-1,891.00
1,560.00
-1,047.00
1,326.00
-930.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-1,510.00
2,420.00
-1,891.00
1,560.00
-1,047.00
1,326.00
-930.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
18.00
14.00
13.00
3.00
15.00
7.00
8.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-1,492.00
2,434.00
-1,878.00
1,563.00
-1,032.00
1,333.00
-922.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,09,088.00
1,15,501.00
1,08,695.00
1,15,820.00
1,11,204.00
1,11,505.00
1,12,242.00
Earnings per share (EPS)
-12.55
20.09
-15.7
12.96
-8.69
11.01
-7.72
Diluted Earnings per share
-12.55
20.09
-15.7
12.96
-8.69
11.01
-7.72
Operating Profit Margin (Excl OI)
-19.38%
23.71%
-19.84%
18.21%
-19.24%
19.35%
-10.11%
Gross Profit Margin
-4.55%
28.46%
-7.39%
27.22%
-4.34%
25.92%
2.15%
PAT Margin
-16.3%
15.36%
-19.86%
13.85%
-12.33%
9.63%
-8.76%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is -41.19% vs 65.45% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is -161.30% vs 229.61% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is -109.01% vs 718.14% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 2,240.00% vs 0.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

Compare Quarterly Results Of Takara Bio, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
9,266.00
83,856.00
-74,590.00
-88.95%
Other Operating Income
0.00
0.00
0.00
Total Operating income
9,266.00
83,856.00
-74,590.00
-88.95%
Raw Material Cost
4,262.00
45,063.00
-40,801.00
-90.54%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
117.00
5,879.00
-5,762.00
-98.01%
Selling and Distribution Expenses
4,820.00
34,962.00
-30,142.00
-86.21%
Other Expenses
167.00
-587.90
754.90
128.41%
Total Expenditure (Excl Depreciation)
10,869.00
80,025.00
-69,156.00
-86.42%
Operating Profit (PBDIT) excl Other Income
-1,603.00
3,831.00
-5,434.00
-141.84%
Other Income
102.00
67.00
35.00
52.24%
Operating Profit (PBDIT)
-334.00
10,559.00
-10,893.00
-103.16%
Interest
117.00
5,879.00
-5,762.00
-98.01%
Exceptional Items
29.00
0.00
29.00
Gross Profit (PBDT)
5,004.00
38,793.00
-33,789.00
-87.10%
Depreciation
1,360.00
6,661.00
-5,301.00
-79.58%
Profit Before Tax
-1,782.00
-1,982.00
200.00
10.09%
Tax
-289.00
483.00
-772.00
-159.83%
Provisions and contingencies
0
0
0.00
Profit After Tax
-1,510.00
-2,341.00
831.00
35.50%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-1,510.00
-2,341.00
831.00
35.50%
Share in Profit of Associates
0
0
0.00
Minority Interest
18.00
-133.00
151.00
113.53%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-1,492.00
-2,474.00
982.00
39.69%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,09,088.00
1,37,900.00
-28,812.00
-20.89%
Earnings per share (EPS)
-12.55
-18.54
5.99
32.31%
Diluted Earnings per share
-12.55
-18.54
5.99
32.31%
Operating Profit Margin (Excl OI)
-19.38%
4.57%
0.00
-23.95%
Gross Profit Margin
-4.55%
5.58%
0.00
-10.13%
PAT Margin
-16.30%
-2.79%
0.00
-13.51%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 926.60 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -41.19% vs 65.45% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 9.10% vs -7.44% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit -149.20 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -161.30% vs 229.61% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -44.57% vs -409.91% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) -43.60 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -109.01% vs 718.14% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 12.10% vs -130.15% in Jun 2024

Quarterly - Interest
Interest 11.70 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 2,240.00% vs 0.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 1,571.43% vs 0.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -19.38%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024